USE OF A COMPOUND MODIFYING AN INTERLEUKIN 5, INTERLEUKIN 6 AND/OR INTERLEUKIN 10 SECRETION FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR ROSACEA TREATMENT

摘要

Compounds (I) that inhibit secretion of interleukin-5, -6 or -10, other than metronidazole, are used to prepare pharmaceutical compositions for treating rosacea. ACTIVITY : Dermatological. MECHANISM OF ACTION : Interleukin secretion inhibitor. Test details are described but no results for the compounds of the claims are given.